BRCA1 and neoplasm: Similarly, clear cell tumours provided somewhat greater evidence against BRCA1 variant pathogenicity before the age of 50 (LR: 0.16 (95% CI: 0.08–0.31), moderate evidence) versus over that age (LR: 0.37 (95% CI: 0.23–0.59), supporting evidence).